 Tusharkanti Ghosh
Concepts (125)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Metabolomics | 4 | 2021 | 704 | 1.050 |
Why?
| | Sequence Analysis, RNA | 1 | 2025 | 450 | 0.760 |
Why?
| | Single-Cell Analysis | 1 | 2025 | 338 | 0.740 |
Why?
| | Computational Biology | 2 | 2025 | 664 | 0.690 |
Why?
| | Lupus Nephritis | 3 | 2025 | 67 | 0.650 |
Why?
| | Software | 1 | 2025 | 678 | 0.630 |
Why?
| | Gene Expression Profiling | 2 | 2025 | 1771 | 0.580 |
Why?
| | Data Interpretation, Statistical | 1 | 2020 | 377 | 0.550 |
Why?
| | Models, Theoretical | 1 | 2020 | 584 | 0.480 |
Why?
| | Immunophenotyping | 3 | 2025 | 329 | 0.450 |
Why?
| | CD8-Positive T-Lymphocytes | 4 | 2025 | 918 | 0.360 |
Why?
| | Metabolome | 2 | 2021 | 366 | 0.280 |
Why?
| | Mass Spectrometry | 2 | 2021 | 740 | 0.260 |
Why?
| | Proteome | 2 | 2022 | 485 | 0.260 |
Why?
| | Interleukin-2 Receptor beta Subunit | 1 | 2025 | 28 | 0.230 |
Why?
| | Transcriptome | 2 | 2022 | 1014 | 0.230 |
Why?
| | Class I Phosphatidylinositol 3-Kinases | 1 | 2025 | 97 | 0.230 |
Why?
| | Arthritis, Rheumatoid | 2 | 2025 | 1178 | 0.210 |
Why?
| | Th17 Cells | 1 | 2025 | 107 | 0.210 |
Why?
| | Interferons | 2 | 2022 | 195 | 0.200 |
Why?
| | Databases, Genetic | 2 | 2021 | 243 | 0.200 |
Why?
| | Common Variable Immunodeficiency | 1 | 2023 | 30 | 0.200 |
Why?
| | Reproducibility of Results | 2 | 2021 | 3356 | 0.190 |
Why?
| | B-Lymphocytes | 2 | 2025 | 859 | 0.190 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2025 | 547 | 0.180 |
Why?
| | Blood | 1 | 2022 | 113 | 0.180 |
Why?
| | Lupus Erythematosus, Systemic | 1 | 2023 | 234 | 0.170 |
Why?
| | Precision Medicine | 1 | 2025 | 434 | 0.170 |
Why?
| | Lymphocyte Activation | 1 | 2025 | 1150 | 0.170 |
Why?
| | Seroconversion | 1 | 2021 | 46 | 0.170 |
Why?
| | Kidney | 2 | 2025 | 1482 | 0.170 |
Why?
| | Discriminant Analysis | 1 | 2020 | 37 | 0.160 |
Why?
| | Algorithms | 2 | 2025 | 1768 | 0.160 |
Why?
| | Least-Squares Analysis | 1 | 2020 | 78 | 0.160 |
Why?
| | Support Vector Machine | 1 | 2020 | 38 | 0.160 |
Why?
| | Decision Trees | 1 | 2020 | 82 | 0.160 |
Why?
| | Toll-Like Receptors | 1 | 2020 | 189 | 0.160 |
Why?
| | Tumor Microenvironment | 1 | 2023 | 703 | 0.150 |
Why?
| | Area Under Curve | 1 | 2020 | 324 | 0.150 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2025 | 1115 | 0.140 |
Why?
| | Multiple Sclerosis | 1 | 2024 | 470 | 0.140 |
Why?
| | ROC Curve | 1 | 2020 | 590 | 0.140 |
Why?
| | Monocytes | 1 | 2020 | 579 | 0.140 |
Why?
| | Tropomyosin | 1 | 2017 | 13 | 0.130 |
Why?
| | Lung Diseases, Interstitial | 1 | 2023 | 654 | 0.120 |
Why?
| | Myosin Heavy Chains | 1 | 2017 | 180 | 0.120 |
Why?
| | Mutation | 2 | 2025 | 4015 | 0.120 |
Why?
| | Drug Liberation | 1 | 2015 | 36 | 0.120 |
Why?
| | Histones | 1 | 2020 | 639 | 0.110 |
Why?
| | Databases, Factual | 1 | 2020 | 1448 | 0.100 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2021 | 1048 | 0.100 |
Why?
| | Heart | 1 | 2017 | 620 | 0.100 |
Why?
| | Humans | 16 | 2025 | 141754 | 0.100 |
Why?
| | Drug Delivery Systems | 1 | 2015 | 363 | 0.090 |
Why?
| | Datasets as Topic | 2 | 2022 | 125 | 0.090 |
Why?
| | Case-Control Studies | 3 | 2025 | 3597 | 0.080 |
Why?
| | Nanoparticles | 1 | 2015 | 484 | 0.080 |
Why?
| | Autoimmunity | 2 | 2025 | 908 | 0.080 |
Why?
| | Heart Defects, Congenital | 1 | 2017 | 884 | 0.070 |
Why?
| | HIV Infections | 1 | 2022 | 3022 | 0.070 |
Why?
| | Nephrocalcinosis | 1 | 2025 | 13 | 0.060 |
Why?
| | Biomarkers | 3 | 2021 | 4190 | 0.060 |
Why?
| | Signal Transduction | 3 | 2025 | 5169 | 0.060 |
Why?
| | STAT5 Transcription Factor | 1 | 2025 | 57 | 0.060 |
Why?
| | Granzymes | 1 | 2025 | 50 | 0.060 |
Why?
| | Interleukin-15 | 1 | 2025 | 101 | 0.060 |
Why?
| | Anti-Citrullinated Protein Antibodies | 1 | 2025 | 118 | 0.050 |
Why?
| | Interleukin-2 | 1 | 2025 | 456 | 0.050 |
Why?
| | Entropy | 1 | 2023 | 43 | 0.050 |
Why?
| | Cytokines | 2 | 2022 | 2100 | 0.050 |
Why?
| | T-Lymphocytes, Helper-Inducer | 1 | 2023 | 136 | 0.050 |
Why?
| | Principal Component Analysis | 1 | 2023 | 198 | 0.050 |
Why?
| | Receptors, Antigen, B-Cell | 1 | 2023 | 133 | 0.050 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2025 | 394 | 0.050 |
Why?
| | Antigen-Presenting Cells | 1 | 2022 | 159 | 0.050 |
Why?
| | T-Lymphocyte Subsets | 1 | 2023 | 415 | 0.040 |
Why?
| | Hypoalbuminemia | 1 | 2021 | 31 | 0.040 |
Why?
| | Middle Aged | 4 | 2025 | 34647 | 0.040 |
Why?
| | Access to Information | 1 | 2021 | 49 | 0.040 |
Why?
| | Citrullination | 1 | 2020 | 13 | 0.040 |
Why?
| | Phenotype | 2 | 2021 | 3177 | 0.040 |
Why?
| | Lymphocytes | 1 | 2023 | 398 | 0.040 |
Why?
| | Seroepidemiologic Studies | 1 | 2021 | 168 | 0.040 |
Why?
| | Female | 6 | 2025 | 75943 | 0.040 |
Why?
| | Interleukin-10 | 1 | 2022 | 310 | 0.040 |
Why?
| | Data Mining | 1 | 2021 | 118 | 0.040 |
Why?
| | Leukocytes, Mononuclear | 1 | 2023 | 574 | 0.040 |
Why?
| | Proportional Hazards Models | 1 | 2023 | 1268 | 0.040 |
Why?
| | RNA, Viral | 1 | 2024 | 693 | 0.040 |
Why?
| | Adult | 4 | 2025 | 39391 | 0.040 |
Why?
| | Fluorescent Antibody Technique | 1 | 2020 | 386 | 0.040 |
Why?
| | Hematopoiesis | 1 | 2021 | 194 | 0.040 |
Why?
| | Regression Analysis | 1 | 2021 | 1023 | 0.040 |
Why?
| | Disease Susceptibility | 1 | 2020 | 353 | 0.040 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2023 | 720 | 0.040 |
Why?
| | Male | 5 | 2025 | 70179 | 0.030 |
Why?
| | Autoantigens | 1 | 2020 | 426 | 0.030 |
Why?
| | Complement Activation | 1 | 2021 | 415 | 0.030 |
Why?
| | Complement System Proteins | 1 | 2021 | 333 | 0.030 |
Why?
| | Inflammation Mediators | 1 | 2020 | 519 | 0.030 |
Why?
| | Inpatients | 1 | 2022 | 512 | 0.030 |
Why?
| | Homeostasis | 1 | 2021 | 636 | 0.030 |
Why?
| | Sarcomeres | 1 | 2017 | 94 | 0.030 |
Why?
| | RNA, Messenger | 1 | 2024 | 2828 | 0.030 |
Why?
| | Comorbidity | 1 | 2021 | 1664 | 0.030 |
Why?
| | RNA Precursors | 1 | 2017 | 156 | 0.030 |
Why?
| | RNA Splicing | 1 | 2017 | 270 | 0.030 |
Why?
| | Elastomers | 1 | 2015 | 29 | 0.030 |
Why?
| | Actins | 1 | 2017 | 424 | 0.030 |
Why?
| | Disease Models, Animal | 1 | 2025 | 4421 | 0.030 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2023 | 1127 | 0.030 |
Why?
| | Proteomics | 1 | 2021 | 1138 | 0.030 |
Why?
| | Mice, Inbred C57BL | 1 | 2025 | 5909 | 0.030 |
Why?
| | Mice | 2 | 2025 | 18109 | 0.030 |
Why?
| | Models, Biological | 1 | 2021 | 1828 | 0.030 |
Why?
| | Autoantibodies | 1 | 2020 | 1475 | 0.020 |
Why?
| | Aged | 2 | 2025 | 24746 | 0.020 |
Why?
| | Heart Ventricles | 1 | 2017 | 753 | 0.020 |
Why?
| | Polymers | 1 | 2015 | 495 | 0.020 |
Why?
| | Hospitalization | 1 | 2021 | 2264 | 0.020 |
Why?
| | Lung Neoplasms | 1 | 2023 | 2567 | 0.020 |
Why?
| | Animals | 2 | 2025 | 37749 | 0.020 |
Why?
| | Adolescent | 1 | 2025 | 22130 | 0.010 |
Why?
| | Young Adult | 1 | 2021 | 13749 | 0.010 |
Why?
| | Child | 1 | 2023 | 22414 | 0.010 |
Why?
|
|
Ghosh's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|